ELISA – News and Features

MSI plans to produce biosensor products for research, diagnostic, biodefense and pharmacogenomic applications.

PerkinElmer to offer researchers a solution for assay development, optimization and conversion.

CENiMED, BioTeZ and Invitek announce their cooperation to develop, produce and market the Recovery-ELISAs for the therapy control of humanized antibodies.

Researchers supported by the National Institute of Dental and Craniofacial Research have developed a device that measures proteins in saliva to indicate a developing disease in the mouth or body.

The companies with further develop biomarkers for a number of pregnancy complications.

The judging panel stated that Regenerative Medicine, '...is eye-catching and easy to read with a clear rationale.'

York Bioanalytical Solutions has announced the launch of its immunoassay service for the bioanalytical support of large molecule developments and the measurement of biomarkers.

Pierce will provide standardized, sensitive multiplex analysis for secreted protein expression in samples submitted by the NIH.

Parties agree to co-market generation of monoclonal antibodies by Antibodies by Design and Chimera’s Imperacer ™assay technology.

Biobarcode™ technology is designed for protein detection, for nucleic acid detection and genomics.